Skip to main content
Clinical Trials/NCT06687486
NCT06687486Active, not recruitingNot Applicable

Effect of Autogenic Relaxation Therapy on Caregivers on Perceived Stress Quality of Life and Caregiver Burden: a Randomized Controlled Study

Seda KARAKAYA ERGUN1 site in 1 country64 target enrollmentStarted: November 7, 2024Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Sponsor
Enrollment
64
Locations
1
Primary Endpoint
Principial

Study Overview

Brief Summary

Caregivers are also faced with multiple stress factors. Autogenic relaxation therapy will help caregivers relax and take time for themselves by getting away from the stressful life they have lived. Although there are various studies on this subject (Chegeni et al. 2018, Seo and Kim 2019, Ramiraz-Garcia et al. 2020, Wang et al. 2021, Bagheri et all 2021, Ozhanlı and Akyuz 2022), there is no study on caregivers as far as we could reach. As a result of this study, nurses will help caregivers, whom they work one-on-one in most areas, to relax, thus helping to increase the quality of patient care in home environments and contributing to the increase in the quality of life of the caregiver. Thus, caregivers will be able to manage care more actively and effectively both at home and in clinics.

Based on this purpose, the aim of the study is to reduce the anxiety level of caregivers, increase the quality of life and reduce the burden of care after autogenic relaxation therapy to be applied to caregivers.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
Single (Participant)

Eligibility Criteria

Ages
18 Years to 89 Years (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Being over 18 years old
  • •Being able to answer data collection forms
  • •Being able to speak Turkish
  • •Being able to provide continuous or partial care to a patient for at least 3 months
  • •Being able to communicate

Exclusion Criteria

  • •Having epilepsy
  • •Not speaking or understanding Turkish
  • •Having a neurological disability
  • •Having had an acute myocardial infarction
  • •Being diagnosed with schizophrenia and major depression
  • •Being addicted to alcohol or drugs
  • •Having a history of loss of consciousness

Arms & Interventions

control

Other

Intervention: kontrol (Other)

intervention

Experimental

Intervention: relaxin (Behavioral)

Outcomes

Primary Outcomes

Principial

Time Frame: 1 month

A decrease in the perceived stress scale score indicates a decrease in stress, an increase in the quality of life scale score indicates an increase in the quality of life, and a decrease in the care burden scale score indicates a decrease in the care burden. The secondary outcome measure is the decrease in the Perceived Stress Scale score, the increase in the Quality of Life Scale Score, and the decrease in the care burden scale score after autogenic relaxation therapy applied to caregivers.

Secondary Outcomes

  • second(3 month)

Investigators

Sponsor
Seda KARAKAYA ERGUN
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Seda KARAKAYA ERGUN

Principal Investigator

Necmettin Erbakan University

Study Sites (1)

Loading locations...

Similar Trials